The journal of immunology IL-33-Induced hematopoietic stem and progenitor cell mobilization depends upon CCR2

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3792-3802

  Kim, Juyang ^a   Kim, Wonyoung ^a   Le, Hongnga T ^b   Moon, U J ^b   Tran, Vuvi G ^b   Kim, Hyun J ^b   Jung, Soyeon ^b   Nguyen, Quang Tam ^b   Kim, Byung Sam ^b   Jun, Jae Bum ^a   Cho, Hong R ^a   Kwon, Byungsuk ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; INTERLEUKIN 33; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 3; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; CCL7 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; INTERLEUKIN 33, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CANDIDA ALBICANS; CELL HOMING; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; MYELOPOIESIS; NONHUMAN; PROTEIN PHOSPHORYLATION; STEM CELL MOBILIZATION; ANIMAL; AUTOGRAFT; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; DRUG EFFECT; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; AUTOGRAFTS; BONE MARROW TRANSPLANTATION; CHEMOKINE CCL7; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; IMMUNITY, INNATE; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID CELLS; MYELOPOIESIS; RECEPTORS, CCR2;

EID: 84907212735     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400176     Document Type: Article

References (35)

1. Liew, F. Y., N. I. Pitman, and I. B. McInnes. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10: 103-110.
2. Kurowska-Stolarska, M., A. Hueber, B. Stolarski, and I. B. McInnes. 2011. Interleukin-33: a novel mediator with a role in distinct disease pathologies. J. Intern. Med. 269: 29-35.
3. Luthi, A. U., S. P. Cullen, E. A. McNeela, P. J. Duriez, I. S. Afonina, C. Sheridan, G. Brumatti, R. C. Taylor, K. Kersse, P. Vandenabeele, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98.
4. Oboki, K., T. Ohno, N. Kajiwara, K. Arae, H. Morita, A. Ishii, A. Nambu, T. Abe, H. Kiyonari, K. Matsumoto, et al. 2010. IL-33 is a crucial amplifier of innate rather than acquired immunity. P roc. Natl. Acad. Sci. USA 107: 18581-18586.
5. Moussion, C., N. Ortega, and J.-P. Girard. 2008. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "alarmin "? PLoS ONE 3: e3331.
6. Carriere, V., L. Roussel, N. Ortega, D. A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J. P. Girard. 2007. IL-33, the I L-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287.
7. Xu, D., W. L. Chan, B. P. Leung, FP. Huang, R. Wheeler, D. Piedrafita, J. H. Robinson, and F. Y. Liew. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187: 787-794.
8. Lö hning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleu kin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
9. Kurowska-Stolarska, M., B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. M irchandani, B. Rana, N. van Rooijen, et al. 2009. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183: 6469-6477.
10. R ank, M. A., T. Kobayashi, H. Kozaki, K. R. Bartemes, D. L. Squillace, and H. Kita. 2009. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 123: 1047-1054.
11. Ali, S., M. Huber, C. Kollewe, S. C. Bischoff, W. Falk, and M. W. Martin. 2007. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104: 18660-18665.
12. Schneider, E., A. F. Petit-Bertron, R. Bricard, M. Levasseur, A. Ramadan, J. P. Girard, A. Herbelin, and M. Dy. 2009. IL-33 activates unprimed murine basophils di rectly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J. Immunol. 183: 3591-3597.
13. Stolarski, B., M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew. 2010. IL-33 exacerbates eosinophil-mediated airway inflammation. J. Immunol. 185: 3472-3480.
14. Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production of T (H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
15. Neill, D. R., S. H . Wong, A. Bellosi, R. J. Flynn, M. Daly, T. K. Langford, C. Bucks, C. M. Kane, P. G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
16. Saenz, S. A., M. C. Siracusa, J. G. Perrigoue, S. P. Spencer, J. F. Urban, Jr., J. E. Tocker, A. L. Budelsky, M. A. Kleinschek, R. A. Kastelein, T. Kambayashi, et al. 2010. IL25 elicits a multipotent progenitor cell population that promotes T (H)2 cytokine responses. Nature 464: 1362-1366.
17. Rankin, A. L., J. B. Mumm, E. Murphy, S. Turner, N. Yu, T. K. McClanahan, P. A. Bourne, R. H. Pierce, R. Kastelein, and S. Pflanz. 2010. IL-33 induces IL-13-dependent cutaneous fibrosis. J. Immunol. 184: 1526-1535.
18. Xu D.,H.R. Jiang,P. Kewin,Y. Li,R. Mu,A.R. Fraser,N. Pitman,M. Kurowska-Stolarska,A.N. McKenzie,I.B. Mc Innes,F.Y. Liew, 2008, IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA, 105, 10913-10918.
19. Adams, G. B., and D. T. Scadden. 2006. The hematopoietic stem cells in its place. Nat. Immunol. 7: 333-337.
20. Wright, D. E., A. J. Wagers, A. P. Gulati, F. L. Johnson, and I. L. Weissman. 2001. Physiological migration of hematopoietic stem and progenitor cells. Science 294: 1933-1936.
21. Massberg, S., P. Schaerli, I. Knezevic-Maramica, M. Köllnberger, N. Tubo, E. A. Moseman, I. V. Huff, T. Junt, A. J. Wagers, I. B. Mazo, and U. H. von Andrian. 2007. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131: 994-1008.
22. Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N. R. Hackett, R. G. Crystal, P. Besmer, D. Lyden, M. A. Moore, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
23. Lé vesque, J. P., J. Hendy, Y. Takamatsu, B. Williams, I. G. Winkler, and P. J. Simmons. 2002. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. 30: 440-449.
24. Petit, I ., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. Ponomaryov, R. S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. G-CSF induces stem cell mobilization by decreasing bone marrow SD F-1 and up-regulating CXCR4. Nat. Immunol. 3: 687-694.
25. Lé vesque, J. P., J. Hendy, Y. Takamatsu, P. J. Simmons, and L. J. Bendall. 2003. Disruption of the CXCR4/CXCL12 chemotactic interaction d uring hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111: 187-196.
26. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zuraws ki, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
27. Brint, E. K., D. Xu, H. Liu, A. Dunne, A. N. McKenzie, L. A. O'Neill, and F. Y. Liew. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tol erance. Nat. Immunol. 5: 373-379.
28. Ueda, Y., M. Kondo, and G. Kelsoe. 2005. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201: 1771-1780.
29. Fukuda, S., H. Bian, A. G. King, and L. M. Pelus. 2007. The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 110: 860-869.
30. Si, Y., C. L. Tsou, K. Croft, and I. F. Charo. 2010. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J. Clin. Invest. 120: 1192-1203.
31. Le, H. T., V. G. Tran, W. Kim, J. Kim, H. R. Cho, and B. Kwon. 2012. IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals. J. Immunol. 189: 287-295.
32. Reeves, E. P., H. Lu, H. L. Jacobs, C. G. Messina, S. Bolsover, G. Gabella, E. O. Potma, A. Warley, J. Roes, and A. W. Segal. 2002. Killing acti vity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291-297.
33. Nelson, M. P., B. S. Christmann, J. L. Werner, A. E. Metz, J. L. Trevor, C. A. Lowell, and C. St eele. 2011. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J. Immunol. 186: 2372-2381.
34. Hazlett, L. D., S. A. McClellan, R. P. Barrett, X. Huang, Y. Zhang, M. Wu, N. van Rooijen, and E. Szliter. 2010. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 51: 1524-1532.
35. Le, H., W. Kim, J. Kim, H. R. Cho, and B. Kwon. 2013. Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies. Front. Immunol. 4: 104 10.3389/fimmu.2013.00104.